SCHEMBL25681122

SCHEMBL25681122

CC1(C)OB(c2cccc(-c3cccc4cc(-c5ccc6ccccc6c5)ccc34)c2)OC1(C)C

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 7/20 0.63
LPL P06858 6/20 0.63
HSD17B1 P14061 2/20 0.37
HSD17B2 P37059 2/20 0.37
TLR8 Q9NR97 1/20 0.36
GSTP1 P09211 1/20 0.36
CYP17A1 P05093 1/20 0.35
CYP19A1 P11511 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
PRMT5 O14744 1/20 0.35
WDR77 Q9BQA1 1/20 0.35
SLC6A2 P23975 3/20 0.34
SLC6A4 P31645 3/20 0.34
SLC6A3 Q01959 3/20 0.34
CHRNA1 P02708 2/20 0.34
CHRNG P07510 2/20 0.34
CHRNB1 P11230 2/20 0.34
CHRNB2 P17787 2/20 0.34
CHRNB4 P30926 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26279835 0.94 LIPG (0.60) LIPGLPLHSD17B1HSD17B2CYP11B1
SCHEMBL25681116 0.94 LIPG (0.57) LIPGLPLHSD17B1HSD17B2TLR8
SCHEMBL25681071 0.94 LIPG (0.63) LIPGLPLHSD17B1HSD17B2GSTP1
SCHEMBL27254524 0.93 LIPG (0.59) LIPGLPLHSD17B1HSD17B2CYP11B1
SCHEMBL27254829 0.93 LIPG (0.59) LIPGLPLHSD17B1HSD17B2CYP11B1
SCHEMBL25681125 0.93 LIPG (0.63) LIPGLPLHSD17B1HSD17B2GSTP1
SCHEMBL25681121 0.92 LIPG (0.51) LIPGLPLHSD17B1HSD17B2TLR8
SCHEMBL25818392 0.92 LIPG (0.55) LIPGLPLHSD17B1HSD17B2TLR8
SCHEMBL27254907 0.92 LIPG (0.69) LIPGLPLHSD17B1HSD17B2GSTP1
SCHEMBL24377078 0.91 LIPG (0.65) LIPGLPLHSD17B1HSD17B2TLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11690292-B2 Organic electronic element comprising a compound for organic electronic element and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-06-27 US disclosed
US-11690292-B2 Organic electronic element comprising a compound for organic electronic element and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-06-27 US disclosed
US-20230129535-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING A COMPOUND FOR ORGANIC ELECTRONIC ELEMENT AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-04-27 US disclosed
US-20230129535-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING A COMPOUND FOR ORGANIC ELECTRONIC ELEMENT AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11690292-B2 Organic electronic element comprising a compound for organic electronic element and an electronic device thereof ESR1, EML4, ORAI2 LIPG 1879/4885LPL 2204/4885HSD17B1 1405/4885
US-20230129535-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING A COMPOUND FOR ORGANIC ELECTRONIC ELEMENT AND AN ELECTRONIC DEVICE THEREOF ESR1, EML4, ORAI2 LIPG 1879/4885LPL 2204/4885HSD17B1 1405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.